Cargando…

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats

Qiliqiangxin capsule (QL) was developed under the guidance of TCM theory of collateral disease and had been shown to be effective and safe for the treatment of heart failure. The present study explored the role of and mechanism by which the herbal compounds QL act on energy metabolism, in vivo, in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Junfang, Wei, Cong, Wang, Hongtao, Tang, Siwen, Jia, Zhenhua, Wang, Lei, Xu, Dengfeng, Wu, Yiling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775405/ https://www.ncbi.nlm.nih.gov/pubmed/24078824 http://dx.doi.org/10.1155/2013/378298

Ejemplares similares

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach
por: Fu, Junzeng, et al.
Publicado: (2018)

Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
por: Leung, Alice Yeuk Lan, et al.
Publicado: (2021)

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure
por: Zhang, Yu, et al.
Publicado: (2019)

The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Wensheng, et al.
Publicado: (2023)

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice
por: Ye, Yong, et al.
Publicado: (2015)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction
por: Wang, Yanyan, et al.
Publicado: (2020)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
por: Yao, Wenming, et al.
Publicado: (2020)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Qiliqiangxin Capsule Modulates Calcium Transients and Calcium Sparks in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Li, Yuxin, et al.
Publicado: (2022)

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015)

High‐fat diet affects skeletal muscle mitochondria comparable to pressure overload‐induced heart failure
por: Heyne, Estelle, et al.
Publicado: (2020)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

Rescue of Pressure Overload‐Induced Heart Failure by Estrogen Therapy
por: Iorga, Andrea, et al.
Publicado: (2016)

Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart
por: Wei, Yidong, et al.
Publicado: (2012)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
por: Schmitz, Boris, et al.
Publicado: (2018)

Myocardial work index: a marker of left ventricular contractility in pressure‐ or volume overload‐induced heart failure
por: Lakatos, Bálint Károly, et al.
Publicado: (2021)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Protective effect of resveratrol against pressure overload-induced heart failure
por: Gupta, Prakash K, et al.
Publicado: (2014)

T cell costimulation blockade blunts pressure overload-induced heart failure
por: Kallikourdis, Marinos, et al.
Publicado: (2017)

Effects of 6-mercaptopurine in pressure overload induced right heart failure
por: Axelsen, Julie Birkmose, et al.
Publicado: (2019)

Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure
por: Heron, Coraline, et al.
Publicado: (2022)

Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy
por: Zhou, Junyang, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Suppression of RBFox2 by Multiple MiRNAs in Pressure Overload-Induced Heart Failure
por: Gu, Mingyao, et al.
Publicado: (2023)

Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
por: Qin, Yating, et al.
Publicado: (2022)

Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-β1/Smad Signaling Pathway Inhibition
por: Bai, Wenwu, et al.
Publicado: (2021)

Right Ventricular Dysfunction and Failure in Chronic Pressure Overload
por: Simon, Marc A., et al.
Publicado: (2011)

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

Cellular hypertrophy occurs before interstitial fibrosis in pressure-overload heart failure
por: Shah, Ravi, et al.
Publicado: (2013)

Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure
por: Patel, Bindiya, et al.
Publicado: (2017)

MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload
por: Ribeiro Junior, Rogério Faustino, et al.
Publicado: (2018)

The GABA(A) Receptor Influences Pressure Overload-Induced Heart Failure by Modulating Macrophages in Mice
por: Bu, Jin, et al.
Publicado: (2021)

Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload
por: Ding, Yuejia, et al.
Publicado: (2020)

A Heart Failure Model Established by Pressure Overload Caused by Abdominal Aortic Contraction in Rat
por: Dai, Wang Sheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7flkskqi9272fgmu63rqcdj1cu